US 11517564
Methods of treatment for cystic fibrosis
granted A61KA61K31/404A61K31/443
Quick answer
US patent 11517564 (Methods of treatment for cystic fibrosis) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/404, A61K31/443, A61K31/4439, A61K31/47